Hjem › Brystkreft › New Hampshire
Kliniske studier for Brystkreft i New Hampshire
16 studier for Brystkreft søker deltakere på steder i New Hampshire.
Offisiell studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Dana-Farber/New Hampshire Oncology-Hematology, Londonderry
RekruttererFase 3
Alder 60 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06377852Testing a Mammography Decision Intervention in a Rural Setting
- Cheshire Medical Center, Keene
- New London Hospital Primary Care, New London
- Newport Health Center, Newport
Rekrutterer
Alder 39 til 49 · Kvinner · Oppdatert 24. sep. 2026 · NCT06522568Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Lebanon
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07085767A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Dartmouth Hitchcock Medical, Lebanon
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06253871Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Dartmouth Hitchcock Medical Center, Lebanon
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06072612Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors
- Dartmouth-Hitchcock Clinic, Lebanon
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07706556ATEMPT 2.0: Adjuvant T-DM1 vs TH
- NH Oncology-Hematology, PA - Payson Center for Cancer Care, Concord
- Dana-Farber Cancer Insitute at Londonderry Hospital, Londonderry
- Solinsky Center for Cancer Care (NH Oncology-Hematology, PA), Manchester
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT04893109MRg-NIRS Imaging System Breast Cancer Trial
- Dartmouth-Hitchcock Medical Center, Lebanon
Rekrutterer
Alder 18 til 83 · Kvinner · Oppdatert 23. jun. 2026 · NCT06400563A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
- Dartmouth-Hitchcock Clinic, Lebanon
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT06258993STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
- Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 5. mai 2026 · NCT05716516De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RekruttererFase 3
Alder 50 til 70 · Alle kjønn · Oppdatert 23. apr. 2026 · NCT04852887Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT02926690Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
- Dartmouth Cancer Center, Lebanon
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. feb. 2026 · NCT07071038Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
- Dartmouth Cancer Center, Lebanon
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 20. nov. 2025 · NCT05900895Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.